Latest news
SCYX Looks 78.3% Undervalued on GF Value™ Despite Challenging Fu - GuruFocusGuruFocus · Mon, 10 Aug 2026 22:06:49 GMTScynexis Q2 Results: EPS beats estimate, sales drop 82% - scanx.tradescanx.trade · Mon, 10 Aug 2026 21:40:46 GMTSCYNEXIS Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 20:50:46 GMTSCYNEXIS (NASDAQ:SCYX) Announces Quarterly Earnings Results, Beats Expectations By $1.14 EPS - MarketBeatMarketBeat · Mon, 10 Aug 2026 20:44:35 GMTScynexis Q2 swings to profit on warrant adjustment; advances drug studies - TradingViewTradingView · Mon, 10 Aug 2026 20:41:00 GMTScynexis (NASDAQ: SCYX) lifts cash and pipeline with Q2 2026 moves - Stock TitanStock Titan · Mon, 10 Aug 2026 20:02:13 GMTSCYNEXIS (NASDAQ:SCYX) Lowered to Strong Sell Rating by Wall Street Zen - MarketBeatMarketBeat · Sat, 08 Aug 2026 07:48:27 GMTSCYNEXIS Inc. R (135.MU) insider ownership and holdings - Yahoo Finance AustraliaYahoo Finance Australia · Fri, 07 Aug 2026 21:42:00 GMT